Since then, STIC lesions have been recognized as potential HGSOC-precursor lesions that share tumor-specific genetic alterations, such as mutations in BRCA1, BRCA2, TP53, and PTEN (15, 16). This evidence concerns the gene TP53 and neoplasm.